Musculoskeletal System Disorder Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: MDA9EEE8EEDEEN
Market Monitor Global

Abstracts

Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.

This report contains market size and forecasts of Musculoskeletal System Disorder in Global, including the following market information:

Global Musculoskeletal System Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Musculoskeletal System Disorder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Rheumatoid Arthritis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Musculoskeletal System Disorder include AB Science, AbGenomics International, Inc., Alder BioPharmaceuticals,Inc., Amgen Inc., Lexicon Pharmaceuticals, Inc., LG Chem, OrthoTrophix, Inc., Tarsa Therapeutics, Inc. and PhytoHealth Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Musculoskeletal System Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Musculoskeletal System Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Musculoskeletal System Disorder Market Segment Percentages, by Type, 2021 (%)

• Rheumatoid Arthritis
• Osteoarthritis
• Osteoporosis
• Others

Global Musculoskeletal System Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Musculoskeletal System Disorder Market Segment Percentages, by Application, 2021 (%)

• Hospitals & Clinics
• Academic & Research Institutes

Global Musculoskeletal System Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Musculoskeletal System Disorder Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Musculoskeletal System Disorder revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Musculoskeletal System Disorder revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AB Science
• AbGenomics International, Inc.
• Alder BioPharmaceuticals,Inc.
• Amgen Inc.
• Lexicon Pharmaceuticals, Inc.
• LG Chem
• OrthoTrophix, Inc.
• Tarsa Therapeutics, Inc.
• PhytoHealth Corporation
• Eisai Co., Ltd
• Astellas Pharma Inc.
• AstraZeneca
• Baxter
• GlaxoSmithKline PLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Musculoskeletal System Disorder Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Musculoskeletal System Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MUSCULOSKELETAL SYSTEM DISORDER OVERALL MARKET SIZE

2.1 Global Musculoskeletal System Disorder Market Size: 2021 VS 2028
2.2 Global Musculoskeletal System Disorder Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Musculoskeletal System Disorder Players in Global Market
3.2 Top Global Musculoskeletal System Disorder Companies Ranked by Revenue
3.3 Global Musculoskeletal System Disorder Revenue by Companies
3.4 Top 3 and Top 5 Musculoskeletal System Disorder Companies in Global Market, by Revenue in 2021
3.5 Global Companies Musculoskeletal System Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Musculoskeletal System Disorder Players in Global Market
  3.6.1 List of Global Tier 1 Musculoskeletal System Disorder Companies
  3.6.2 List of Global Tier 2 and Tier 3 Musculoskeletal System Disorder Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Musculoskeletal System Disorder Market Size Markets, 2021 & 2028
  4.1.2 Rheumatoid Arthritis
  4.1.3 Osteoarthritis
  4.1.4 Osteoporosis
  4.1.5 Others
4.2 By Type - Global Musculoskeletal System Disorder Revenue & Forecasts
  4.2.1 By Type - Global Musculoskeletal System Disorder Revenue, 2017-2022
  4.2.2 By Type - Global Musculoskeletal System Disorder Revenue, 2023-2028
  4.2.3 By Type - Global Musculoskeletal System Disorder Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Musculoskeletal System Disorder Market Size, 2021 & 2028
  5.1.2 Hospitals & Clinics
  5.1.3 Academic & Research Institutes
5.2 By Application - Global Musculoskeletal System Disorder Revenue & Forecasts
  5.2.1 By Application - Global Musculoskeletal System Disorder Revenue, 2017-2022
  5.2.2 By Application - Global Musculoskeletal System Disorder Revenue, 2023-2028
  5.2.3 By Application - Global Musculoskeletal System Disorder Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Musculoskeletal System Disorder Market Size, 2021 & 2028
6.2 By Region - Global Musculoskeletal System Disorder Revenue & Forecasts
  6.2.1 By Region - Global Musculoskeletal System Disorder Revenue, 2017-2022
  6.2.2 By Region - Global Musculoskeletal System Disorder Revenue, 2023-2028
  6.2.3 By Region - Global Musculoskeletal System Disorder Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Musculoskeletal System Disorder Revenue, 2017-2028
  6.3.2 US Musculoskeletal System Disorder Market Size, 2017-2028
  6.3.3 Canada Musculoskeletal System Disorder Market Size, 2017-2028
  6.3.4 Mexico Musculoskeletal System Disorder Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Musculoskeletal System Disorder Revenue, 2017-2028
  6.4.2 Germany Musculoskeletal System Disorder Market Size, 2017-2028
  6.4.3 France Musculoskeletal System Disorder Market Size, 2017-2028
  6.4.4 U.K. Musculoskeletal System Disorder Market Size, 2017-2028
  6.4.5 Italy Musculoskeletal System Disorder Market Size, 2017-2028
  6.4.6 Russia Musculoskeletal System Disorder Market Size, 2017-2028
  6.4.7 Nordic Countries Musculoskeletal System Disorder Market Size, 2017-2028
  6.4.8 Benelux Musculoskeletal System Disorder Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Musculoskeletal System Disorder Revenue, 2017-2028
  6.5.2 China Musculoskeletal System Disorder Market Size, 2017-2028
  6.5.3 Japan Musculoskeletal System Disorder Market Size, 2017-2028
  6.5.4 South Korea Musculoskeletal System Disorder Market Size, 2017-2028
  6.5.5 Southeast Asia Musculoskeletal System Disorder Market Size, 2017-2028
  6.5.6 India Musculoskeletal System Disorder Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Musculoskeletal System Disorder Revenue, 2017-2028
  6.6.2 Brazil Musculoskeletal System Disorder Market Size, 2017-2028
  6.6.3 Argentina Musculoskeletal System Disorder Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Musculoskeletal System Disorder Revenue, 2017-2028
  6.7.2 Turkey Musculoskeletal System Disorder Market Size, 2017-2028
  6.7.3 Israel Musculoskeletal System Disorder Market Size, 2017-2028
  6.7.4 Saudi Arabia Musculoskeletal System Disorder Market Size, 2017-2028
  6.7.5 UAE Musculoskeletal System Disorder Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AB Science
  7.1.1 AB Science Corporate Summary
  7.1.2 AB Science Business Overview
  7.1.3 AB Science Musculoskeletal System Disorder Major Product Offerings
  7.1.4 AB Science Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.1.5 AB Science Key News
7.2 AbGenomics International, Inc.
  7.2.1 AbGenomics International, Inc. Corporate Summary
  7.2.2 AbGenomics International, Inc. Business Overview
  7.2.3 AbGenomics International, Inc. Musculoskeletal System Disorder Major Product Offerings
  7.2.4 AbGenomics International, Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.2.5 AbGenomics International, Inc. Key News
7.3 Alder BioPharmaceuticals,Inc.
  7.3.1 Alder BioPharmaceuticals,Inc. Corporate Summary
  7.3.2 Alder BioPharmaceuticals,Inc. Business Overview
  7.3.3 Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Major Product Offerings
  7.3.4 Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.3.5 Alder BioPharmaceuticals,Inc. Key News
7.4 Amgen Inc.
  7.4.1 Amgen Inc. Corporate Summary
  7.4.2 Amgen Inc. Business Overview
  7.4.3 Amgen Inc. Musculoskeletal System Disorder Major Product Offerings
  7.4.4 Amgen Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.4.5 Amgen Inc. Key News
7.5 Lexicon Pharmaceuticals, Inc.
  7.5.1 Lexicon Pharmaceuticals, Inc. Corporate Summary
  7.5.2 Lexicon Pharmaceuticals, Inc. Business Overview
  7.5.3 Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Major Product Offerings
  7.5.4 Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.5.5 Lexicon Pharmaceuticals, Inc. Key News
7.6 LG Chem
  7.6.1 LG Chem Corporate Summary
  7.6.2 LG Chem Business Overview
  7.6.3 LG Chem Musculoskeletal System Disorder Major Product Offerings
  7.6.4 LG Chem Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.6.5 LG Chem Key News
7.7 OrthoTrophix, Inc.
  7.7.1 OrthoTrophix, Inc. Corporate Summary
  7.7.2 OrthoTrophix, Inc. Business Overview
  7.7.3 OrthoTrophix, Inc. Musculoskeletal System Disorder Major Product Offerings
  7.7.4 OrthoTrophix, Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.7.5 OrthoTrophix, Inc. Key News
7.8 Tarsa Therapeutics, Inc.
  7.8.1 Tarsa Therapeutics, Inc. Corporate Summary
  7.8.2 Tarsa Therapeutics, Inc. Business Overview
  7.8.3 Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Major Product Offerings
  7.8.4 Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.8.5 Tarsa Therapeutics, Inc. Key News
7.9 PhytoHealth Corporation
  7.9.1 PhytoHealth Corporation Corporate Summary
  7.9.2 PhytoHealth Corporation Business Overview
  7.9.3 PhytoHealth Corporation Musculoskeletal System Disorder Major Product Offerings
  7.9.4 PhytoHealth Corporation Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.9.5 PhytoHealth Corporation Key News
7.10 Eisai Co., Ltd
  7.10.1 Eisai Co., Ltd Corporate Summary
  7.10.2 Eisai Co., Ltd Business Overview
  7.10.3 Eisai Co., Ltd Musculoskeletal System Disorder Major Product Offerings
  7.10.4 Eisai Co., Ltd Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.10.5 Eisai Co., Ltd Key News
7.11 Astellas Pharma Inc.
  7.11.1 Astellas Pharma Inc. Corporate Summary
  7.11.2 Astellas Pharma Inc. Business Overview
  7.11.3 Astellas Pharma Inc. Musculoskeletal System Disorder Major Product Offerings
  7.11.4 Astellas Pharma Inc. Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.11.5 Astellas Pharma Inc. Key News
7.12 AstraZeneca
  7.12.1 AstraZeneca Corporate Summary
  7.12.2 AstraZeneca Business Overview
  7.12.3 AstraZeneca Musculoskeletal System Disorder Major Product Offerings
  7.12.4 AstraZeneca Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.12.5 AstraZeneca Key News
7.13 Baxter
  7.13.1 Baxter Corporate Summary
  7.13.2 Baxter Business Overview
  7.13.3 Baxter Musculoskeletal System Disorder Major Product Offerings
  7.13.4 Baxter Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.13.5 Baxter Key News
7.14 GlaxoSmithKline PLC
  7.14.1 GlaxoSmithKline PLC Corporate Summary
  7.14.2 GlaxoSmithKline PLC Business Overview
  7.14.3 GlaxoSmithKline PLC Musculoskeletal System Disorder Major Product Offerings
  7.14.4 GlaxoSmithKline PLC Musculoskeletal System Disorder Revenue in Global Market (2017-2022)
  7.14.5 GlaxoSmithKline PLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Musculoskeletal System Disorder Market Opportunities & Trends in Global Market
Table 2. Musculoskeletal System Disorder Market Drivers in Global Market
Table 3. Musculoskeletal System Disorder Market Restraints in Global Market
Table 4. Key Players of Musculoskeletal System Disorder in Global Market
Table 5. Top Musculoskeletal System Disorder Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Musculoskeletal System Disorder Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Musculoskeletal System Disorder Revenue Share by Companies, 2017-2022
Table 8. Global Companies Musculoskeletal System Disorder Product Type
Table 9. List of Global Tier 1 Musculoskeletal System Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Musculoskeletal System Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Musculoskeletal System Disorder Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Musculoskeletal System Disorder Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Musculoskeletal System Disorder Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Musculoskeletal System Disorder Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Musculoskeletal System Disorder Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Musculoskeletal System Disorder Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Musculoskeletal System Disorder Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Musculoskeletal System Disorder Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Musculoskeletal System Disorder Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Musculoskeletal System Disorder Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Musculoskeletal System Disorder Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Musculoskeletal System Disorder Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Musculoskeletal System Disorder Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Musculoskeletal System Disorder Revenue, (US$, Mn), 2023-2028
Table 30. AB Science Corporate Summary
Table 31. AB Science Musculoskeletal System Disorder Product Offerings
Table 32. AB Science Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 33. AbGenomics International, Inc. Corporate Summary
Table 34. AbGenomics International, Inc. Musculoskeletal System Disorder Product Offerings
Table 35. AbGenomics International, Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 36. Alder BioPharmaceuticals,Inc. Corporate Summary
Table 37. Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Product Offerings
Table 38. Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Inc. Corporate Summary
Table 40. Amgen Inc. Musculoskeletal System Disorder Product Offerings
Table 41. Amgen Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 42. Lexicon Pharmaceuticals, Inc. Corporate Summary
Table 43. Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Product Offerings
Table 44. Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 45. LG Chem Corporate Summary
Table 46. LG Chem Musculoskeletal System Disorder Product Offerings
Table 47. LG Chem Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 48. OrthoTrophix, Inc. Corporate Summary
Table 49. OrthoTrophix, Inc. Musculoskeletal System Disorder Product Offerings
Table 50. OrthoTrophix, Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 51. Tarsa Therapeutics, Inc. Corporate Summary
Table 52. Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Product Offerings
Table 53. Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 54. PhytoHealth Corporation Corporate Summary
Table 55. PhytoHealth Corporation Musculoskeletal System Disorder Product Offerings
Table 56. PhytoHealth Corporation Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 57. Eisai Co., Ltd Corporate Summary
Table 58. Eisai Co., Ltd Musculoskeletal System Disorder Product Offerings
Table 59. Eisai Co., Ltd Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 60. Astellas Pharma Inc. Corporate Summary
Table 61. Astellas Pharma Inc. Musculoskeletal System Disorder Product Offerings
Table 62. Astellas Pharma Inc. Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 63. AstraZeneca Corporate Summary
Table 64. AstraZeneca Musculoskeletal System Disorder Product Offerings
Table 65. AstraZeneca Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 66. Baxter Corporate Summary
Table 67. Baxter Musculoskeletal System Disorder Product Offerings
Table 68. Baxter Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)
Table 69. GlaxoSmithKline PLC Corporate Summary
Table 70. GlaxoSmithKline PLC Musculoskeletal System Disorder Product Offerings
Table 71. GlaxoSmithKline PLC Musculoskeletal System Disorder Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Musculoskeletal System Disorder Segment by Type in 2021
Figure 2. Musculoskeletal System Disorder Segment by Application in 2021
Figure 3. Global Musculoskeletal System Disorder Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Musculoskeletal System Disorder Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Musculoskeletal System Disorder Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Musculoskeletal System Disorder Revenue in 2021
Figure 8. By Type - Global Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 9. By Application - Global Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 10. By Region - Global Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 11. By Country - North America Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 12. US Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 16. Germany Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 17. France Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 24. China Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 28. India Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 30. Brazil Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Musculoskeletal System Disorder Revenue Market Share, 2017-2028
Figure 33. Turkey Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Musculoskeletal System Disorder Revenue, (US$, Mn), 2017-2028
Figure 37. AB Science Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbGenomics International, Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LG Chem Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. OrthoTrophix, Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. PhytoHealth Corporation Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eisai Co., Ltd Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Astellas Pharma Inc. Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AstraZeneca Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Baxter Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GlaxoSmithKline PLC Musculoskeletal System Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)